Ceramide in primary astrocytes from cerebellum: metabolism and role in cell proliferation
Tóm tắt
Cerebellar astrocytes are equipped with an efficient molecular machinery able to control the levels, and possibly the subcellular location, of ceramide. The major metabolic routes that contribute to the maintenance and variation of the cellular ceramide include ceramide biosynthesis, byde novo pathway or sphingosine recycling, ceramide formation from complex sphingolipids degradation and ceramide catabolism. In cerebellar astrocytes from rat cerebellum a peculiar metabolism of sphingomyelin occurs. This includes the preponderance of acidic sphingomyelinase, paralleled by a deficiency of the neutral Mg2+-dependent enzyme, as well as the presence of an extra-Golgi form of sphingomyelin synthase, which shares many characteristics with PC-PLC. Moreover these cells are characterized by a high efficiency in converting sphingosine to ceramide, possibly functional to the role played by astrocytes in the prevention of neuronal damage by high sphingosine concentration. Recent evidence demonstrates that a change of ceramide level is one of the key steps in the chain of reactions elicited by mitogenic stimuli. In fact, low cellular levels of ceramide characterize, and appear to be required for, the proliferation of cerebellar astrocytes. In particular mitogenic stimuli, such as basic fibroblast growth factor (bFGF), rapidly down regulate the cellular levels of ceramide by stimulating sphingomyelin synthase. Ceramide acts as an intracellular physiological inhibitor of cell growth, being able to counteract the effect of bFGF by inhibiting the MAP kinase pathway. Although many questions remain in this field, the present knowledge strongly supports that ceramide represents a crucial member within lipid mediators, involved in the signaling pathways underlying cell proliferation in cerebellar astrocytes.
Tài liệu tham khảo
Riboni L, Viani P, Bassi R, Prinetti A, Tettamanti G. The role of sphingolipids in the process of signal transduction. Prog Lipid Res 1997; 36: 153–195.
Perry DK, Hannun YA. The role of ceramide in cell signaling. Biochim Biophys Acta 1998; 1436: 233–243.
Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 2000; 1485: 63–99.
Chao MV. Ceramide: a potential second messenger in the nervous system. Mol Cell Neurosci 1995; 6: 91–96.
Ariga T, Jarvis WD, Yu RK. Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 1998; 39: 1–16.
Futerman AH. The roles of ceramide in the regulation of neuronal growth and development. Biochem (Moscow) 1998; 63: 89–100.
Mathias S, Peña LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J 1998; 335: 465–480.
Goswami R, Dawson G. Does ceramide play a role in neural cells apoptosis? J Neurosci Res 2000; 60: 141–149.
Dobrowsky RT, Werner MH, Castellino M, Chao MV, Hannun YA. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994; 265: 1596–1599.
Galve-Roperh I, Sánchez C, Cortés ML, Gomez del Pulgar T, Izquierdo M, Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000; 6: 313–319.
Riboni L, Viani P, Bassi R, Stabilini A, Tettamanti G. Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocyte in primary culture. GLIA 2000; 32: 137–145.
Luberto C, Hannun YA. Sphingolipid metabolism in the regulation of bioactive molecules. Lipids 1999; 34: S5-S11.
Riboni L, Viani P, Tettamanti G. Estimating sphingolipid metabolism and trafficking in cultured cells using radiolabeled compounds. Meth Enzymol 1999; 311: 656–682.
Blázquez C, Geelen MJH, Velasco G, Guzmán M. The AMP-activated protein kinase prevents ceramide synthesisde novo and apoptosis in astrocytes. FEBS Lett 2001; 489: 149–153.
Levade T, Jaffrézou J-P. Signalling sphingomyelinases: which, where, how and why? Biochim Biophys Acta 1999; 1438: 1–17.
Jayadev S, Hannun YA. Ceramide: role in growth inhibitory cascades. J Lipid Med Cell Signal 1996; 14: 295–301.
Riboni L, Prinetti A, Bassi R, Tettamanti G. Formation of bioactive sphingoid molecules from exogenous sphingomyelin in primary cultures of neurons and astrocytes. FEBS Lett 1994; 352: 323–326.
Kolesnick RN, Krönke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol 1998; 60: 643–665.
Tettamanti G, Riboni L. Gangliosides turnover and neural cells function: a new perspective. Prog Brain Res 1994; 101: 77–100.
Riboni L, Bassi R, Prinetti A, Viani P, Tettamanti G. Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture. Biochem J 1999; 338: 147–151.
Riboni L, Viani P, Bassi R, Giussani P, Tettamanti G. Cultured granule cells and astrocytes from cerebellum differ in metabolizing sphingosine. J Neurochem 2000; 75: 503–510.
Vos JP, de Haas CGM, van Golde LMG, Lopes-Cardozo M. Relationships between phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin metabolism in cultured oligodendrocytes. J Neurochem 1997; 68: 1252–1260.
Riboni L, Viani P, Bassi R, Giussani P, Tettamanti G. Basic fibroblast growth factor-induced proliferation of primary astrocytes. Evidence for the involvement of sphingomyelin biosynthesis. J Biol Chem 2001; 276: 12797–12804.
Kallen K-J, Allan D, Whatmore J, Quinn P. Synthesis of surface sphingomyelin in the plasma membrane recycling pathway of BHK cells. Biochim Biophys Acta 1994; 1191: 52–58.
van Helvoort A, van’t Hoff W, Ritsema T, Sandra A, van Meer G. Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby Canine Kidney) cells. J Biol Chem 1994; 269: 1763–1769.
Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997; 20: 570–577.
Ha BK, Bishop GA, King JS, Burry RW. Corticotropin releasing factor induces proliferation of cerebellar astrocytes. J Neurosci Res 2000; 62: 789–798.
Souza Lima FR, Goncalves N, Carvalho F, Gomes A, Sampaio de Freitas M, Moura-Neto V. Thyroid hormone action on astroglial cells from distinct brain regions during development. Int J Devl Neurosci 1998; 16: 19–27.
Trentin AG, Rosenthal D, Maura Neto V. Thyroid hormone and conditioned medium effects on astroglial cells from hypothyroid and normal rat brain: factor secretion, cell differentiation and proliferation. J Neurosci Res 1995; 41: 409–417.
Morrison RS, Keating RF, Moskal JR. Basic fibroblast growth factor and epidermal growth factor exert differential trophic effects on CNS neurons. J Neurosci Res 1988; 21: 71–79.
Vergelli M, Mazzanti B, Ballerini C, Gran B, Amaducci L, Massacesi L. Tranforming growth factor β1 inhibits the proliferation of rat astrocytes induced by serum and growth factors. J Neurosci Res 1995; 40: 127–133.
Emoto N, Gozales A-M, Walicke PA, et al. Basic fibroblast growth factor in the nervous system: identification of specific loci of basic FGF expression in the rat brain. Growth Factors 1989; 2: 21–29.
Kawamata T, Speliotes EK, Finklestein SP. The role of polypeptide growth factors in recovery from stroke. Adv Neurol 1997; 73: 377–382.
Logan A, Frautschy SA, Gonzales A-M, Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high affinity receptors following a localized cortical brain injury. J Neurosci 1992; 12: 3828–3837.
Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 1992; 76: 792–798.
Biesiada E, Razandi M, Levin ER. Egr-1 activates basic fibroblast growth factor transcription-mechanistic implications for astrocyte proliferation. J Biol Chem 1996; 271: 18576–18581.
Kurino M, Fukunaga K, Ushio Y, Miyamoto E. Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes. J Neurochem 1996; 67: 2246–2255.
Neary JT, Kang Y, Bu Y, Yu E, Akong K, Peters CM. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J Neurosci 1999; 19: 4211–4220.
Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 1996; 19: 13–18.
Sánchez C, Galve-Roperh I, Rueda D, Guzmán M. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol 1998; 54: 834–843.
Coroneos E, Martinez M, McKenna S, Kester M. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem 1995; 270: 23305–23309.
Guzmán M, Galve-Roperh I, Sánchez C. Ceramide: a new second messenger of cannabinoid action. Trends Pharmacol Sci 2001; 22: 19–22.
Cook HW, Palmer FBStC, Byers DM, Spence MW. Isolation of plasma membranes from cultured glioma cells and application to evaluation of sphingomyelin turnover. Anal Biochem 1988; 174: 552–560.
Luberto C, Hannun YA. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. J Biol Chem 1998; 273: 14550–14559.
Schinkmann KA, Kim TA, Avraham S. Glutamate-stimulated activation of DNA synthesis via mitogen-activated protein kinase in primary astrocytes: involvement of protein kinase C and related adhesion focal tyrosine kinase. J Neurochem 2000; 74: 1931–1940.
Kobayashi H, Honma S, Nakahata N, Ohizumi Y. Involvement of phosphatidylcholine-specific phospholipase C in tromboxane A2-induced activation of mitogen-activated protein kinase in astrocytoma cells. J Neurochem 2000; 74: 2167–2173.
Casaccia-Bonnefil P, Aibel L, Chao MV. Central glial and neuronal populations display differential sensitivity to ceramidedependent cell death. J Neurosci Res 1996; 43: 382–389.
Whitmarsh AJ, Davis RJ. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci 1998; 23: 481–485.